![]() |
½ÃÀ庸°í¼
»óÇ°ÄÚµå
1300791
¼¼°èÀÇ ÁÖ»ê±â °¨¿° ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : °¨¿° À¯Çüº°, Áø´Üº°, Ä¡·áº°, Åõ¿© °æ·Îº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Perinatal Infections Market Size Study & Forecast, by Infection Type, By Diagnosis, By Treatment, By Route of Administration, By End-user, and Regional Analysis, 2023-2030 |
ÁÖ»ê±â °¨¿°Àº ÀӽŠÁß ¶Ç´Â ºÐ¸¸ Á÷ÈÄ¿¡ ¹ß»ýÇÏ´Â °¨¿°À¸·Î ¸ðü¿¡¼ žƳª ½Å»ý¾Æ¿¡°Ô Àü¿°µÉ ¼ö ÀÖ´Â °¨¿°À» ¸»ÇÕ´Ï´Ù.
ÀÌ·¯ÇÑ °¨¿°Àº ÀϹÝÀûÀ¸·Î ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, °õÆÎÀÌ, ±â»ýÃæ¿¡ ÀÇÇØ ¹ß»ýÇÏ¸ç »ê¸ð¿Í ÅÂ¾Æ ¸ðµÎ¿¡°Ô ½É°¢ÇÑ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀϹÝÀûÀÎ ÁÖ»ê±â °¨¿°¿¡´Â °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º °¨¿°, Àå ¹ÙÀÌ·¯½º °¨¿°, »ý½Ä±â Æ÷Áø, ÀÓÁú, Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º µîÀÌ ÀÖ½À´Ï´Ù. ÁÖ»ê±â °¨¿° ȯÀÚÀÇ ±ÞÁõ, Ä¡·á °¡´É¼º¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤ºÎ À̴ϼÅƼºê Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇöÀå °Ë»ç¿¡ ´ëÇÑ Ãß¼¼ Áõ°¡´Â ¼¼°è ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ´Â °¡Àå µÎµå·¯Áø ¿äÀÎÀÔ´Ï´Ù.
¶ÇÇÑ, Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) À¯º´·ü Áõ°¡´Â ¼¼°è ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, HIV¿¡ °¨¿°µÈ ÀÓ»êºÎ´Â ¹ÙÀÌ·¯½º ¸ð¼º °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ç×·¹Æ®·Î¹ÙÀÌ·¯½º Ä¡·á(ART)¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. HIV.gov¿¡ µû¸£¸é 2021³â¿¡´Â ¼¼°èÀûÀ¸·Î ¾à 3,840¸¸ ¸íÀÌ HIV¿¡ °¨¿°µÆÀ¸¸ç, ÀÌ Áß 170¸¸ ¸íÀº ¼Ò¾Æ(15¼¼ ¹Ì¸¸), 3,670¸¸ ¸íÀº ¼ºÀÎÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼ºÀÎÀÎ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ, 2021³â¿¡´Â ¼¼°èÀûÀ¸·Î ¾à 150¸¸ ¸íÀÌ HIV¿¡ °¨¿°µÇ¾ú½À´Ï´Ù. ÀÌ¿¡ µû¶ó HIV ¿¹¹æ ¹× Ä¡·á¿¡ ´ëÇÑ Àνİú ³ë·ÂÀÌ ³ô¾ÆÁ³°í, ARTÀÇ °¡¿ë¼ºÀº ÁÖ»ê±â HIV °¨¿° °¡´É¼ºÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÇ¾î ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ ¼Ò¸Å ¾à±¹¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Áø´Ü Å×½ºÆ®ÀÇ ±â¼ú ¹ßÀüÀº ÇâÈÄ ¸î ³âµ¿¾È ´Ù¾çÇÑ ¼öÀÍ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ³ôÀº Ä¡·á ºñ¿ëÀ¸·Î ÀÎÇØ 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°è ÁÖ»ê±â °¨¿° ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â Áø·á ½ÃÁ¡ °Ë»ç¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, Á¤ºÎ À̴ϼÅƼºê Áõ°¡, °³ÀÎÈ µÈ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2022³â½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ»ê±â °¨¿°ÀÇ ±ÞÁõ, Ä¡·á °¡´É¼º¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼Ò¸Å ¾à±¹ ¼ö¿ä Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡´Â ÀÌ Áö¿ª Àüü ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆľÇÇÏ°í ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.
Global Perinatal Infections Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Perinatal infections are infections that occur during pregnancy or shortly after delivery, which can be transmitted from the mother to the fetus or newborn. These infections is generally caused by bacteria, viruses, fungi, or parasites that exhibit a serious impact on both the mother and the infant. Several common perinatal infections include cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, others. The surging cases of perinatal infections, growing awareness regarding treatment availability, rising number of government initiatives, spurring demand for personalized medicine, rising inclination towards point-of-care testing are the most prominent factors that are propelling the market demand across the globe.
In addition, the rising incidences of Human Immunodeficiency Virus (HIV) are exhibiting a positive influence on market growth across the globe. Pregnant women with HIV require antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission of the virus. Without proper treatment, the risk of transmission is high and leads to perinatal HIV infection, which can have serious health consequences for the newborn. According to HIV.gov, in 2021it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thereby, the growing awareness and initiatives for HIV prevention and treatment, along with the availability of ART is aids in lessening the chances of perinatal HIV infection, which, in turn, accelerates the global market growth. Moreover, the growing demand for retail pharmacies, as well as the increasing technological advancements in diagnostic tests presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and high cost involved in treatment are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Perinatal Infections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: